Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization (2023)

First Author: Zheng J

Attributed to: The Avon Longitudinal Study of Parents and Children: An international resource for population genomics and lifecourse epidemiology. Core Programme Support 2011-2015 and Core programme support 2014-2019 funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Arthritis & Rheumatology

Issue: 10